The landscape of managing diabetes is advancing with the introduction of transdermal GLP-1 delivery . These innovative devices offer a possibly more comfortable alternative to shots for individuals dealing with type 2 diabetes . These patches deliver glucagon-like peptide-1 directly through the epidermis, circumventing the necessity for frequent in